BRC Therapeutics Founder and CEO George Hodgin to Speak at Nucleate Global Summit 2026

ConferenceNeutral

AI Analysis

Summary

BRC Therapeutics announced that founder and CEO George Hodgin will speak at the Nucleate Global Summit 2026 in Monterey, California on a panel discussing leadership and decision-making lessons from special operations applied to drug development.

Importance:2/10

Sentiment:

0.00

conferenceleadershipneurological diseasesinflammatory diseases

Related Companies

$GBCYD

Read the original article

Published by PR Newswire Biotech on August 11, 2026 3:00 PM

Read Original